Concomitant high expression of ERα36, EGFR and HER2 is associated with aggressive behaviors of papillary thyroid carcinomas
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Concomitant high expression of ERα36, EGFR and HER2 is associated with aggressive behaviors of papillary thyroid carcinomas ; volume:7 ; number:1 ; day:25 ; month:9 ; year:2017 ; pages:1-10 ; date:12.2017
Scientific reports ; 7, Heft 1 (25.9.2017), 1-10, 12.2017
- Creator
-
Dai, Yu-Jie
- Contributor
-
Qiu, Yi-Bo
Jiang, Rong
Xu, Man
Zhao, Le
Chen, George G.
Liu, Zhi-Min
SpringerLink (Online service)
- DOI
-
10.1038/s41598-017-12478-1
- URN
-
urn:nbn:de:101:1-2018082913373215036676
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Dai, Yu-Jie
- Qiu, Yi-Bo
- Jiang, Rong
- Xu, Man
- Zhao, Le
- Chen, George G.
- Liu, Zhi-Min
- SpringerLink (Online service)
Other Objects (12)
Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas
Häufigkeit der EGFR- und HER2-Ausprägung sowie HER2-Genamplifikation beim Gallengangskarzinom
Phase I clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion
Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis
The expression of stromal biomarkers in small papillary thyroid carcinomas
Concomitant uveal melanoma and papillary thyroid carcinoma: a case report
HER2/neu, EGFR und c-Met-Mutation/ Amplifikation
EGFR Expression in HER2-Driven Breast Cancer Cells
EGFR und HER2-neu-Expression im oralen Plattenepithelkarzinom
Single HER2-positive tumor cells are detected in initially HER2-negative breast carcinomas using the DEPArray™–HER2-FISH workflow
Erratum to: phase 1 clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion
The clinical significance of BRAFV600E mutations in pediatric papillary thyroid carcinomas
Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas
Häufigkeit der EGFR- und HER2-Ausprägung sowie HER2-Genamplifikation beim Gallengangskarzinom
Phase I clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion
Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis
The expression of stromal biomarkers in small papillary thyroid carcinomas
Concomitant uveal melanoma and papillary thyroid carcinoma: a case report
HER2/neu, EGFR und c-Met-Mutation/ Amplifikation
EGFR Expression in HER2-Driven Breast Cancer Cells
EGFR und HER2-neu-Expression im oralen Plattenepithelkarzinom
Single HER2-positive tumor cells are detected in initially HER2-negative breast carcinomas using the DEPArray™–HER2-FISH workflow
Erratum to: phase 1 clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion
The clinical significance of BRAFV600E mutations in pediatric papillary thyroid carcinomas
Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas
Häufigkeit der EGFR- und HER2-Ausprägung sowie HER2-Genamplifikation beim Gallengangskarzinom
Phase I clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion
Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis
The expression of stromal biomarkers in small papillary thyroid carcinomas
Concomitant uveal melanoma and papillary thyroid carcinoma: a case report
HER2/neu, EGFR und c-Met-Mutation/ Amplifikation
EGFR Expression in HER2-Driven Breast Cancer Cells
EGFR und HER2-neu-Expression im oralen Plattenepithelkarzinom
Single HER2-positive tumor cells are detected in initially HER2-negative breast carcinomas using the DEPArray™–HER2-FISH workflow
Erratum to: phase 1 clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion